Physician profile
Aaron S Geller
NPI 1447516828
$1,310.49
in general payments reported to CMS, 2019-2025
11 companies · $297 in 2025
The $297 reported for 2025 was less than what a typical Clinical Neurophysiology provider received nationally (typical 2025 total: $435).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $271 · 2020: $195 · 2021: $68.28 · 2024: $478 · 2025: $297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $776.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $775.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sk Life Science, INC. | $729.10 | 2020-2025 | Xcopri |
| Supernus Pharmaceuticals, INC. | $293.38 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $60.44 | 2025 | |
| Ucb, INC. | $58.23 | 2019 | |
| Eisai INC. | $51.09 | 2020-2021 | |
| Sunovion Pharmaceuticals INC. | $30.92 | 2021 | |
| Aprecia Pharmaceuticals, LLC | $29.29 | 2019-2020 | |
| Livanova USA, INC. | $17.50 | 2019 | |
| Aquestive Therapeutics, INC. | $15.06 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $12.79 | 2019 | |
| Merz North America, INC. | $12.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Geller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.